Seeking Capital or Licensing Deal? Here’s Why Digital RESI March is Important

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series; Caitlin Dolegowski, Marketing Specialist, LSN

Finding the right capital or channel partner is a numbers game, which means that you need to get in front of potential partners regularly. This is why the Redefining Early Stage Investments (RESI) conference takes place five times each year. You never know when a connection will surface that leads to a partnership, so you must be in the game to make it happen.

RESI is different from other partnering conferences in that it does real-time dynamic matching. The team at Life Science Nation (LSN) pre-loads investor profiles from mandates collected and stored in the LSN Investor Database. That is a big deal because (at most partnering events) investors typically have very light or even empty profiles. Because LSN has all the investors and licensing partners’ updated profiles in our database, this makes a huge difference in the quality of RESI meetings.

LSN can match based on fit, which in turn means great meetings can happen as both parties are looking for each other. Instead of booking a meeting and realizing there is no fit (which is common at other partnering conferences), RESI is unique because:

1. There is the option to filter partners by capital investment and licensing mandates and match on stage of development and product.
2. Most investor and licensing partner profiles are uploaded from our curated partnering database, so the user does not need to update their profile, unless they choose to, which has been a game-changer.
3. Scientist-entrepreneurs and fundraising CEOs can opt to upgrade to a premier profile as part of RESI Premier Partnering to access deeper detailed investor mandates, which also include valuable contact information.

Another facet of Digital RESI March is the variety of panels focused on educating the entrepreneur on key components to partnering in the life science and health care early-stage arena. Hear straight from relevant investors and industry experts. These panels are created with the same intent and spirit of our partnering platform – To bring quality content with the early-stage life science entrepreneur in mind. Hear best practices, lessons learned, and valuable insight from our panelists. These panels are available to attendees live or their recordings are available on the meeting platform. Check out the panelists presenting at Digital RESI March below.

Tuesday, March 22, 11 AM EDT

Early-Stage Therapeutics

Bringing the Newest Therapies to the Clinic

Yaniv Sneor Founder Mid Atlantic Bio Angels (Moderator)	Cynthia Cai, PhD, MBA Venture Partner Viva BioInnovator	Catello Somma, MBA Associate ;TVM Capital Life Science
Scott Weiner Partner, Amzak Health	Sa’ar Yaniv Director, Business Development, Fortress Biotech

Tuesday, March 22, 2 PM EDT

Digital Health & Wellness

Silver-Tech Focusing on Preventative Care

Brenda Hogan, MBA Senior Investment Manager Ontario Capital Growth Corporation (OCGC) (Moderator)	Moshe Bellows, JD General Partner Maccabee Ventures	Seemant Jauhari Managing Partner HealthXCapital

Tuesday, March 22, 3 PM EDT

Seed Funds

Investing in the Earliest Stage Companies

Andy Merken Partner & Co-Chair, Life Sciences Burns & Levinson (Moderator)	Dipty Desai, PhD Co-Chair, TiE Global Health TiE Angels	Matt Martin, PhD, MBA Venture Partner Pathway Bioventures
	Gita Reinitz Principal (NFX Bio) NFX

Tuesday, March 22, 4 PM EDT

Tales from the Road: AI Innovators on their Fundraising Journey

Chelsea Sumner, PharmD NALA Healthcare AI Startups Lead NVIDIA (Moderator)	Davide Vigano Co-Founder & CEO Sensoria	Ramji Srinivasan Co-Founder & CEO Teiko.bio
Himanshu Misra, PhD CEO Enliten AI	Leila Pirhaji, PhD Founder & CEO ReviveMed

Wednesday, March 23, 10AM EDT

Mental & Behavioral Health Panel

Investing in Technologies that Help Manage Well-Being

Lana Ghanem, MBA Managing Director Hikma Ventures	Raj Pallapothu Managing Director Bio 9 Ventures	Mayank Taneja, MBA Director, Venture Investments OSF Healthcare Ventures
	Charlie Hartwell Operating Partner Bridge Builders Collaborative

Wednesday, March 23, 11 AM EDT

Age-Tech Devices

Seniors Embrace Innovative Medtech for Better Quality of Life

Lise Pape Trustee Future Care Capital	Rick Robinson Vice President, Startup Engagement AARP Innovation Labs	Clarence Tan, PhD, MBA Co-Founder ABBY by GOGOTECH

Wednesday, March 23, 2 PM EDT

Medtech Strategics

Large Corporations Seeking External Innovation in MedTech

David Uffer Senior Partner Alira Health Ventures (Moderator)	Lana Caron, MBA Innovation Lead Philips Health Technology Ventures	Juan Cueva, PhD, MBA Director, New Ventures & Early Innovation Partnering Johnson & Johnson Innovation
	Tali Hirsch Director, Venture Investments Fresenius Medical Care Ventures

Wednesday, March 23, 3 PM EDT

AI Drug Discovery and Development

How AI is Accelerating Therapeutic Advancement

Rafael Rosengarten, PhD Co-Founder, Board Director & Executive Committee Member The Alliance for Artificial Intelligence in Healthcare (Moderator)	Galym Imanbayev, MD, MBA Partner Lightspeed Venture Partners	Linda Li Managing Director Vickers Venture Partners
	Thea Pham, PhD Associate, Investments OCV Partners

Wednesday, March 23, 4 PM EDT

Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey

Greg Mannix VP of International Business Development Life Science Nation (Moderator)	Russell McAllister, MBA CEO Bold Therapeutics	Brian Hess, MBA CEO RevBio
	Alan Lucas Co-Founder, CEO & Director Navigation Sciences

Thursday, March 24, 11 AM EDT

Precision Medicine

Improving Outcomes through a Patient-Tailored Approach

David Crean President & CEO Coast BioVentures	Niall Kerrigan Program Manager Plug and Play Ventures	Eric de la Fortelle Managing Partner Cathay Capital

Thursday, March 24, 1 PM EDT

Cell & Gene Therapy

The Next Generation of Therapeutic Technologies

Nishta Rao Managing Director – Life Science First Republic Bank (Moderator)	Cynthia Lavoie President & Chief Investment Officer Centre for Commercialization of Regenerative Medicine	Scott Galasinski Global Head, Business Development, Licensing & Strategy, Biopharmaceuticals R&D AstraZeneca
Megan Krench Director, Investments Sanofi Ventures	Yury Kukushkin Investment Director JDRF T1D Fund	Alicia Yin, PhD Vice President 6 Dimensions Capital

Thursday, March 24, 2 PM EDT

Defining AI Investment

AI-Exclusive Investors Share Their Perspectives

Amit Garg, MBA Co-Founder & Managing Partner Tau Ventures (Moderator)	Navid Alipour, JD, MBA Managing Partner Analytics Ventures	Isabel Fox General Partner Outsized Ventures
	Gayathri Radhakrishnan, MBA Senior Director, Venture Capital – AI Fund Micron Technology

Thursday, March 24, 4 PM EDT

Tales from the Road: Age-Tech Innovators on their Fundraising Journey

Jackie Marshall-Cyrus Director Jackie Marshall-Cyrus & Associates Ltd (Moderator)	Char Hu, PhD Co-Founder & CEO The Helper Bees	Meredith Oppenheim Founder & CEO Vitality Society
	Kyle Rand Co-Founder & CEO Rendever